Is Less More: Does Leukopenia Predict Remission in Patients with Inflammatory Bowel Disease Receiving Thiopurine Treatment?

被引：2
|
作者：
Gisbert, Javier P. [1 ,2 ]
机构：
[1] Hosp Univ La Princesa, Gastroenterol Unit, Inst Invest Sanitaria Princesa, Madrid 28669, Spain
[2] Hosp Univ La Princesa, Ctr Invest Biomed Red Enfermedades Hepaticas & Di, Madrid 28669, Spain
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 01期
关键词：
AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE; NEUTROPENIA;
D O I：
10.1007/s10620-014-3481-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 50 条
  • [11] Patients with inflammatory bowel disease who are intolerant to thiopurine treatment
    Karling, P.
    Gensmyr-Singer, H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1594 - I1594
  • [12] Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease
    Gearry, RB
    Barclay, ML
    Burt, MJ
    Collett, JA
    Chapman, BA
    Roberts, RL
    Kennedy, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (04) : 395 - 400
  • [13] Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy
    Bhairavi Balram
    Joshua Lubov
    Yves Theoret
    Waqqas Afif
    Alain Bitton
    Gary Wild
    Peter L. Lakatos
    Talat Bessissow
    Digestive Diseases and Sciences, 2021, 66 : 1650 - 1657
  • [14] Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy
    Balram, Bhairavi
    Lubov, Joshua
    Theoret, Yves
    Afif, Waqqas
    Bitton, Alain
    Wild, Gary
    Lakatos, Peter L.
    Bessissow, Talat
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1650 - 1657
  • [15] NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
    Matsuoka, Katsuyoshi
    INTESTINAL RESEARCH, 2020, 18 (03) : 275 - 281
  • [16] Thiopurine treatment in inflammatory bowel disease - Reply
    Schwab, Matthias
    CLINICAL PHARMACOKINETICS, 2007, 46 (09) : 805 - 805
  • [17] Fecal Calprotectin Does Not Predict Endoscopic Remission in Inflammatory Bowel Disease Reply
    D'Haens, Geert
    Vermeire, Severine
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : E81 - E81
  • [18] Influences of Thiopurine Methyltransferase Genotype and Activity on Thiopurine-induced Leukopenia in Korean Patients With Inflammatory Bowel Disease A Retrospective Cohort Study
    Kim, Jae Hak
    Cheon, Jae Hee
    Hong, Seong Soo
    Eun, Chang Soo
    Byeon, Jeong-Sik
    Hong, Sung Yi
    Kim, Bo-Young
    Kwon, Soon-ho
    Kim, Seung Won
    Han, Dong Soo
    Yang, Suk-Kyun
    Kim, Won Ho
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (10) : E242 - E248
  • [19] No increased risk for infections with thiopurine-induced leukopenia in inflammatory bowel disease patients without a variant in thiopurine S-methyltransferase
    Broekman, M.
    Coenen, M.
    van Marrewijk, C.
    Wanten, G.
    Derijks, L.
    Vermeulen, S.
    Wong, D.
    Klungel, O.
    Verbeek, A.
    Hooymans, P.
    Scheffer, H.
    Guchelaar, H. -J.
    de Jong, D.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S247 - S247
  • [20] Mutagenicity and Potential Carcinogenicity of Thiopurine Treatment in Patients with Inflammatory Bowel Disease
    Nguyen, Truc
    Vacek, Pamela M.
    O'Neill, Patrick
    Colletti, Richard B.
    Finette, Barry A.
    CANCER RESEARCH, 2009, 69 (17) : 7004 - 7012
12345